Prostate-specific antigen screening among transgender women in clinical care: A retrospective chart review study
Open Access
- 14 August 2025
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 43 (11) , 664.e1-664.e9
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (1017493)
- Robert Wood Johnson Foundation
- University of Michigan Institute for Research on Women and Gender
- Gilead Sciences Inc
This publication has 33 references indexed in Scilit:
- Prostate-Specific Antigen Values in Transgender Women Receiving EstrogenJAMA, 2024
- Prostate Cancer Screening Uptake in Transgender WomenJAMA Network Open, 2024
- Prostate Cancer Screening Patterns Among Sexual and Gender Minority IndividualsEuropean Urology, 2021
- Association Between Gender-Affirming Surgeries and Mental Health OutcomesJAMA Surgery, 2021
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Frequency and distribution of primary site among gender minority cancer patients: An analysis of U.S. national surveillance dataCancer Epidemiology, 2018
- Prostate-Specific Antigen–Based Screening for Prostate CancerJAMA, 2018
- The influence of physician recommendation on prostate-specific antigen screeningUrologic Oncology: Seminars and Original Investigations, 2015
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Lifetime and Recent Prostate Specific Antigen (PSA) Screening of Men for Prostate Cancer in CanadaCanadian Journal of Public Health, 2006